Bio-Rad Laboratories, Inc.
BIO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $653,000 | $651,600 | $585,400 | $667,475 |
| % Growth | 0.2% | 11.3% | -12.3% | – |
| Cost of Goods Sold | $309,600 | $306,300 | $279,400 | $325,563 |
| Gross Profit | $343,400 | $345,300 | $306,000 | $341,912 |
| % Margin | 52.6% | 53% | 52.3% | 51.2% |
| R&D Expenses | $71,300 | $60,500 | $73,500 | $79,624 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $206,800 | $207,700 | $208,800 | $204,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$42 |
| Operating Expenses | $278,100 | $268,200 | $282,300 | $283,582 |
| Operating Income | $65,300 | $77,100 | $23,700 | $58,330 |
| % Margin | 10% | 11.8% | 4% | 8.7% |
| Other Income/Exp. Net | -$496,400 | $336,900 | $59,700 | -$967,230 |
| Pre-Tax Income | -$431,100 | $414,000 | $83,400 | -$908,900 |
| Tax Expense | $89,200 | $96,200 | $19,400 | -$193,100 |
| Net Income | -$341,900 | $317,800 | $64,000 | -$715,800 |
| % Margin | -52.4% | 48.8% | 10.9% | -107.2% |
| EPS | -12.7 | 11.67 | 2.29 | -25.57 |
| % Growth | -208.8% | 409.6% | 109% | – |
| EPS Diluted | -12.7 | 11.67 | 2.29 | -25.57 |
| Weighted Avg Shares Out | 26,923 | 27,226 | 27,941 | 27,997 |
| Weighted Avg Shares Out Dil | 26,923 | 27,228 | 27,955 | 27,997 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $14,700 | $36,200 | $15,900 |
| Interest Expense | $12,300 | $12,600 | $12,000 | $12,185 |
| Depreciation & Amortization | $34,200 | $50,600 | $38,100 | $49,300 |
| EBITDA | -$384,600 | $477,200 | $133,500 | -$847,400 |
| % Margin | -58.9% | 73.2% | 22.8% | -127% |